So you seem to be letting us down slowly. It’s interesting how a few of you seem to know what’s ahead but you have to couch it in possibilities, like going down to $1.60 is somehow a good thing.
If I were to take the cynical view, I would say your mission was to help keep the PPS above $2 to get listed to the Amex. That was a noble mission but you seem to be out of air. Given the numerous off topic posts like “Papaya Leaf” or “the NNV Web site banter”, I would conclude that you folks are temporarily between jobs.
Here are some useful tasks for you to work on:
1) Discuss the significance of up listing from the OTC. This has been discussed but the info is scattered. What are the key price break points, etc. How does that change how the stock is traded. Would there be less price manipulation?
2) Can you tell us if the up-listing paper work has been filed? That should be a matter of record, no?
3) What do you think would be the best scenario for announcing block buster news, for example, would it be better for the PPS to wait for up-listing then put out the news?
4) What was briefed by our NNVC leadership at the Biotechnology Association on 4/19?
5) I think I read on one of the posts that NNVC would provide HIVCide to patients terminally ill with AIDS in the Africa. That is very intriguing. First of all, is it real? And, second, if it is real, could the data be used to pre-IND filing for HIVCide?
6) No news Monday based on my take, otherwise you would be speculating about it and the PPS would have spiked near the end of Friday.
Capisce?
